Target intelligence / Profile preview

Type 1 Cytotoxic T Lymphocyte (Tc1)

Target
Tc1
Molecular classification
T cell subset, Cytotoxic T lymphocyte
01

Overview

Tc1 lymphocytes are a subset of CD8+ T cells that play a critical role in cell-mediated immunity, particularly against viral infections and tumors. They are characterized by their production of IFN-γ and TNF-α, as well as their potent cytolytic activity mediated by granzyme B and perforin. Differentiation into the Tc1 lineage is driven by IL-12 and IFN-γ, and regulated by transcription factors such as T-bet, Blimp-1 and IRF4. Imbalances in Tc1 populations can contribute to disease susceptibility, while adoptive transfer of Tc1 cells shows promise in cancer immunotherapy.

Other names
Tc1 LymphocyteType 1 CD8+ T cellIFN-γ-producing CD8+ T cell
02

Mechanism of action

Tc1 cells exert their cytotoxic function primarily through the release of granzyme B and perforin, leading to target cell apoptosis. They also secrete IFN-γ and TNF-α, which contribute to immune regulation and direct anti-tumor effects.

03

Biological functions

Cell-mediated cytotoxicityAntiviral immunityAntitumor immunityCytokine production (IFN-γ, TNF-α)Immune regulation
04

Disease associations

Viral infectionCancerAutoimmune disease (potential)Immunodeficiency
05

Safety considerations

Cytokine storm (potential)Off-target cytotoxicityAutoimmunity (potential)
06

Interacting drugs

IL-12 (inducer)

3 more in the full profile.

07

Biomarkers

CD8 expressionIFN-γ productionTNF-α productionGranzyme B expressionPerforin expressionT-bet expressionBlimp-1 expressionIRF4 expression

Beyond the preview

Go deeper on Type 1 Cytotoxic T Lymphocyte (Tc1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Type 1 Cytotoxic T Lymphocyte (Tc1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call